{
    "id": 103,
    "premise": "none",
    "hypothesis": "an irreversible inhibitor that is targeted to the HER2 kinase domain may overcome treatment resistance and be effective in breast cancer patients",
    "label": "entailment",
    "explanation": "an irreversible inhibitor that is targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients.\nTargeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance.",
    "results": {
        "semantic validity": true,
        "premise": null,
        "hypothesis": "an irreversible inhibitor that is targeted to the HER2 kinase domain may overcome treatment resistance and be effective in breast cancer patients",
        "refined explanation": "an irreversible inhibitor that is targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients.\nTargeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance.",
        "refined iteration": 1,
        "history explanation": [
            "0 iteration: an irreversible inhibitor that is targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients.\nTargeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance.",
            "1 iteration: an irreversible inhibitor that is targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients.\nTargeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: True"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_103_0\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitor :: \"entity \u21d2 bool\"\\n  Irreversible :: \"entity \u21d2 bool\"\\n  TargetedTo :: \"entity \u21d2 entity \u21d2 bool\"\\n  HER2KinaseDomain :: \"entity\"\\n  Expected :: \"event \u21d2 bool\"\\n  Effective :: \"event \u21d2 bool\"\\n  Drug :: \"entity \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n  BreastCancerPatients :: \"entity \u21d2 bool\"\\n  Mutation :: \"entity \u21d2 bool\"\\n  TyrosineKinase :: \"entity \u21d2 bool\"\\n  Targeting :: \"event \u21d2 bool\"\\n  Overcome :: \"event \u21d2 bool\"\\n  TreatmentResistance :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: An irreversible inhibitor that is targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y e. Inhibitor x \u2227 Irreversible x \u2227 TargetedTo x HER2KinaseDomain \u2227 Expected e \u2227 Effective e \u2227 Drug x \u2227 For e y (BreastCancerPatients y)\"\\n\\n(* Explanation 2: Targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance. *)\\naxiomatization where\\n  explanation_2: \"\u2203e x. Mutation HERV777L \u2227 Inhibitor x \u2227 Irreversible x \u2227 TyrosineKinase x \u2227 Targeting e \u2227 Overcome e \u2227 TreatmentResistance e\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Inhibitor x \u2227 Irreversible x \u2227 TargetedTo x HER2KinaseDomain\"\\n  (* Hypothesis: An irreversible inhibitor that is targeted to the HER2 kinase domain may overcome treatment resistance and be effective in breast cancer patients. *)\\n shows \"\u2203e x y. Inhibitor x \u2227 Irreversible x \u2227 TargetedTo x HER2KinaseDomain \u2227 Overcome e \u2227 TreatmentResistance e \u2227 Effective e \u2227 For e y (BreastCancerPatients y)\"\\nproof -\\n  (* From the premise, we have the information about an irreversible inhibitor targeted to the HER2 kinase domain. *)\\n  from asm have \"Inhibitor x \u2227 Irreversible x \u2227 TargetedTo x HER2KinaseDomain\" <ATP>\\n  (* We have the logical relation Implies(A, B), Implies(an irreversible inhibitor is targeted to the HER2 kinase domain, expected to be an effective drug for breast cancer patients) *)\\n  (* A is from explanatory sentence 1, B is from explanatory sentence 1. *)\\n  (* Since we have an irreversible inhibitor targeted to the HER2 kinase domain, we can infer it is expected to be an effective drug for breast cancer patients. *)\\n  then have \"Inhibitor x \u2227 Irreversible x \u2227 TargetedTo x HER2KinaseDomain \u2227 Expected e \u2227 Effective e \u2227 Drug x \u2227 For e y (BreastCancerPatients y)\" for e y <ATP>\\n  (* We also have the information from explanatory sentence 2 that targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance. *)\\n  (* There is a logical relation Implies(C, D), Implies(targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor, may overcome treatment resistance) *)\\n  (* Both C and D are from explanatory sentence 2. *)\\n  (* Since we have an irreversible inhibitor and targeting information, we can infer overcoming treatment resistance. *)\\n  then obtain e where \"Mutation HERV777L \u2227 Inhibitor x \u2227 Irreversible x \u2227 TyrosineKinase x \u2227 Targeting e \u2227 Overcome e \u2227 TreatmentResistance e\" <ATP>\\n  (* Combining the information from both explanations, we can conclude that an irreversible inhibitor targeted to the HER2 kinase domain may overcome treatment resistance and be effective in breast cancer patients. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: an irreversible inhibitor is targeted to the HER2 kinase domain\\nB: expected to be an effective drug for breast cancer patients\\nC: targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor\\nD: may overcome treatment resistance\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(an irreversible inhibitor is targeted to the HER2 kinase domain, expected to be an effective drug for breast cancer patients)\\n--------\\nImplies(C, D)\\nImplies(targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor, may overcome treatment resistance)\\n--------\\n\\nDerived Implications:\\n'}",
            "1 iteration: {'syntactic validity': True, 'error code': '', 'solving time': 12.323330879211426, 'proof tactics': ['Sledgehammering...', 'zipperposition found a proof...', 'cvc4 found a proof...', 'cvc4: Try this: using assms by blast (1 ms)', 'cvc4 found a proof...', 'zipperposition: Found duplicate proof', 'cvc4 found a proof...', 'verit found a proof...', 'cvc4: Found duplicate proof', 'vampire found a proof...', 'cvc4: Found duplicate proof', 'verit: Found duplicate proof', 'e found a proof...', 'zipperposition found a proof...', 'e: Found duplicate proof', 'vampire: Found duplicate proof', 'zipperposition: Found duplicate proof', 'zipperposition found a proof...', 'zipperposition: Found duplicate proof', 'Done'], 'code': 'theory clinical_103_1\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitor :: \"entity \u21d2 bool\"\\n  Targeted :: \"entity \u21d2 entity \u21d2 bool\"\\n  Effective :: \"entity \u21d2 bool\"\\n  BreastCancerPatient :: \"entity \u21d2 bool\"\\n  Expected :: \"entity \u21d2 bool\"\\n  HER2KinaseDomain :: \"entity\"\\n  Targeting :: \"entity \u21d2 entity \u21d2 bool\"\\n  Irreversible :: \"entity \u21d2 bool\"\\n  OvercomeResistance :: \"entity \u21d2 bool\"\\n  HERV777LMutation :: \"entity\"\\n\\n(* Explanation 1: An irreversible inhibitor that is targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients. *)\\naxiomatization where\\n  explanation_1: \"\u2200e. Inhibitor e \u2227 Targeted e HER2KinaseDomain \u2227 Effective e \u2227 BreastCancerPatient e \u27f6 Expected e\"\\n\\n(* Explanation 2: Targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance. *)\\naxiomatization where\\n  explanation_2: \"\u2203e. Targeting e HERV777LMutation \u2227 Inhibitor e \u2227 Irreversible e \u2227 OvercomeResistance e\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Inhibitor(e) \u2227 Targeted e HER2KinaseDomain \u2227 OvercomeResistance e \u2227 Effective e \u2227 BreastCancerPatient e\"\\n  (* Hypothesis: An irreversible inhibitor that is targeted to the HER2 kinase domain may overcome treatment resistance and be effective in breast cancer patients. *)\\n shows \"\u2203e. Inhibitor e \u2227 Targeted e HER2KinaseDomain \u2227 OvercomeResistance e \u2227 Effective e \u2227 BreastCancerPatient e\"\\nproof -\\n  (* From the premise, we have the known information about the inhibitor being targeted to the HER2 kinase domain, overcoming resistance, being effective, and related to breast cancer patients. *)\\n  from asm have \"Inhibitor e \u2227 Targeted e HER2KinaseDomain \u2227 OvercomeResistance e \u2227 Effective e \u2227 BreastCancerPatient e\" <ATP>\\n  (* There is a logical relation Implies(A, B), Implies(an irreversible inhibitor is targeted to the HER2 kinase domain, expected to be an effective drug for breast cancer patients) *)\\n  (* A is from explanatory sentence 1, B is from explanatory sentence 1. *)\\n  (* We already have the inhibitor being targeted to the HER2 kinase domain, so we can infer it being effective for breast cancer patients. *)\\n  then have \"\u2203e. Inhibitor e \u2227 Targeted e HER2KinaseDomain \u2227 OvercomeResistance e \u2227 Effective e \u2227 BreastCancerPatient e\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: an irreversible inhibitor is targeted to the HER2 kinase domain\\nB: expected to be an effective drug for breast cancer patients\\nC: targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor\\nD: may overcome treatment resistance\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(an irreversible inhibitor is targeted to the HER2 kinase domain, expected to be an effective drug for breast cancer patients)\\n--------\\nImplies(C, D)\\nImplies(targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor, may overcome treatment resistance)\\n--------\\n\\nDerived Implications:\\n'}"
        ]
    }
}